Clinical trial
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
NCT00116090 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00116090 |
|---|---|
| Title | Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study |
| Official title | Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Uveitis, Cancer, Infection, Mortality, Immunosuppression |
| Enrollment | 6,300 |
| Start date | Jun 16, 2005 |
| Completion | Apr 21, 2008 |
| First posted | Jun 27, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: